Conformis Growth Hamstrung by Aetna Denials in 2019

Conformis reported 4Q19 orthopedic revenue of USD $19.9 million, -9.8% vs. 4Q18, with full-year 2019 revenue of $77.4 million, -13.8% vs. 2018. The company faced a challenging year due to Aetna coverage denials and portfolio gaps with the lack of a cementless knee. Aetna updated its policy in December 2019 but again declined to cover...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us